Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes
Friday, 9 May 2025 () A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop universal influenza vaccines that induce a more robust immune response against various virus subtypes, including both human and avian strains.
As the weather warms up, and dogs are out and about more, it's important to start discussing pet vaccination options with your veterinarian. Dr. Natalie Marks, a veterinarian, shares the latest..